Bradford Amman
Equibles does not estimate personal net worth.
About Bradford Amman
Earlier roles on record: CFO at Vivos Therapeutics, Inc. (VVOS) until July 31, 2026. Vivos Therapeutics, Inc. reported in an 8-K filed August 3, 2026 that Bradford Amman resigned as Chief Financial Officer and Secretary, effective July 31, 2026. The proxy statement of Vivos Therapeutics, Inc. reports total compensation of $705,919 for Bradford Amman in fiscal 2024, including a base salary of $267,637. Disclosed compensation is on record for 6 fiscal years. Bradford Amman has spoken on 2 earnings calls across 1 company, most recently for Vivos Therapeutics, Inc. on April 15, 2026. The companies whose calls Bradford Amman spoke on are classified in the Healthcare sector.
“On July 31, 2026, Bradford Amman resigned as Chief Financial Officer and Secretary of the Company, and from all other officer and committee positions held by reason of his employment, effective as of that date.”
Bradford Amman on recent calls
“A copy of our earnings release is available on the Investor Relations section of our website at www.vivos.com. With me on the call today is Kurt Huntsman, Vivos Chairman and Chief Executive Officer.”
“A copy of our earnings press release is available on the Investor Relations section of our website at www.vivos.com. With me on the call today is Kirk Huntsman, Vivos' Chairman and Chief Executive Officer.”
Affiliation history
-
Start not stated–2026-07-31
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Vivos Therapeutics, Inc. (VVOS) | Chief Financial Officer | $267,637 | $705,919 |
| 2023 | Vivos Therapeutics, Inc. (VVOS) | Chief Financial Officer | $313,575 | $400,040 |
| 2022 | Vivos Therapeutics, Inc. (VVOS) | Chief Financial Officer | $256,532 | $492,919 |
| 2021 | Vivos Therapeutics, Inc. (VVOS) | Chief Financial Officer | $230,182 | $1,106,092 |
| 2020 | Vivos Therapeutics, Inc. (VVOS) | Chief Financial Officer | $181,167 | $268,938 |
| 2019 | Vivos Therapeutics, Inc. (VVOS) | Chief Financial Officer (principal accounting officer) | $180,000 | $297,220 |